{
    "2021-02-25": [
        [
            {
                "time": "",
                "original_text": "康龙化成：短期投资策略：预计康龙化成超跌反弹【公司研究】",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "短期投资策略",
                        "超跌反弹"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【异动股】康龙化成(03759-HK)涨3%",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "涨3%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(03759.HK)遭FMR LLC减持20.86万股 减持股份",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "FMR LLC",
                        "减持",
                        "20.86万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【CXO行业点评】板块回调不改CXO行业持续高景气【安信医药马帅团队】",
                "features": {
                    "keywords": [
                        "CXO行业",
                        "板块回调",
                        "高景气"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}